Pharmaceutical Marketing Merck “Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research‚ and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997‚ Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited‚ a fully integrated
Premium Pharmaceutical industry Pharmacology Clinical trial
GROUP PROJECT ON NIRMA LTD. SUBJECT: ACCOUNT FOR MANAGERS ACKNOWLEDGEMENT Financial analysis is essential for problem analysis and decision making for any organization. It has been a great pleasure to work on this project and has been an enriching learning experience. We are very grateful to the director of our college‚ GLS-ICT (MBA)‚ Mr. Hitesh Ruparel for giving us this valuable opportunity. We would like to express our heartfelt gratitude towards the professor in-charge Prof
Premium Balance sheet Generally Accepted Accounting Principles Depreciation
Pharmaceutical Advertising Living in a culture that is so heavily influenced by media and advertising‚ it is almost impossible to open a magazine‚ watch television‚ or even walk down the street without seeing an advertisement for prescription drugs. Since its start in the early 19th century‚ the pharmaceutical industry has expanded to become one of the fastest growing‚ most influential and successful industries today. Over the years‚ many factors such as innovative technologies‚ new regulations
Premium Pharmacology Marketing Pharmacy
Pharmaceutical Industry’s Marketing Practices (Against) Marketing is the process by which companies determine what products or services may be of interest to customers‚ and the strategy to use in sales‚ communications and business development. Research and advertising Is a big part of marketing. Marketing involve doing lots of research and is the process by which companies determine what products or service the public wants or needs in order to target the market. Pharmaceutical industry
Premium Pharmacology Marketing Advertising
MANAGEMENT INDUSTRY ANALYSIS NOTES STRATEGIC ANALYSIS: INDUSTRY ANALYSIS “When an industry with a reputation for difficult economics meets a manager with a reputation for excellence‚ it is usually the industry that keeps its reputation intact.” Warren Buffet DEEPAK DATTA UTA MBA 2011 DKD Strategy Analysis Mission Goals and Objectives External Environment Internal Environment The Strategic Management Process Strategy Formulation Business-Level Corporate-Level Strategy Strategy International
Premium Strategic management Barriers to entry
Analysis of Macro-Strategy Dynamics: Automotive Industry 1.1 1.2 Background and scope India is one of the largest markets and one of the fastest growing markets in the world for an automotive industry. By 2015 the annual vehicle sales are projected to increase by 4 million units per year. In the year 2010 India was crowned as the second fastest growing automobile market in the world after china‚ and is a home to 40 million cars in which 37 million are produced in the country. India
Premium Automotive industry Automotive industry by country Volkswagen Group
1. Introduction The purpose of this report is to critically assess current purchasing and supply management practices in pharmaceutical industry‚ while looking at such companies as “Pfizer Inc.” and “Eli Lilly and Company”. Globalization‚ technological advances and increased worldwide competition has led to more complex supply chains in the pharmaceutical industry. It is important to acknowledge the increased exposure of these supply chains to risk. ‘The purpose of risk management is to ensure that
Premium Management Supply chain management Risk management
company saw an increase in scale. His sons Malvinder Mohan Singh and Shivinder Mohan Singh sold the company to the Japanese company Daiichi Sankyo in June 2008. [edit] Trading In 1998‚ Ranbaxy entered the United States‚ the world’s largest pharmaceuticals market and now the biggest market for Ranbaxy‚ accounting for 28% of Ranbaxy’s sales in 2005.[citation needed] For the twelve months ending on 31 December 2005‚ the company’s global sales were at US $1‚178 million with overseas markets accounting
Premium Ranbaxy Laboratories Generic drug
OVERVIEW – INDIAN PHARMACEUTICALINDUSTRY | | 1.1 | Current Scenario | 6 | 1.2 | Major Pharmaceutical Companies | 10 | 1.3 | Government Initiatives | 12 | 1.4 | Oncology Segment | 15 | | LUNG CANCER | | 2.1 | World Scenario | 21 | 2.2 | Indian Scenario | 22 | 2.3 | About Lung Cancer | 30 | 2.4 | Stages of Lung Cancer | 36 | 2.5 | Causes of Lung Cancer | 46 | | LONG LIFE PHARMACEUTICALS PVT. LTD. | | 3.1 | Vision and Mission | 48 | 3.2 | Board of Directors | 49 | 3.3 | Contract
Premium Cancer Lung cancer Oncology
Safety Implementations Table of Contents 1 Abstract 4 2 Introduction 5 3 Safe Drug Development Process in Pharmaceutical Companies 6 4 Pharmaceutical Unit Operation Safety Measures 10 4.1 Weighing and dispensing 10 4.2 Charging and discharging 10 4.3 Liquid separations 10 4.4 Filtration 11 4.5 Compounding 11 4.6 Drying 11 5 Biosafety Levels 12 5.1 Level 1 12 5.2 Level 2 12 5.3 Level 3 12 5.4 Level 4 13 6 Personal Protective Equipment 13 6.1 What is PPE? 13 6.2 OSHA Standards
Premium Occupational safety and health Personal protective equipment Pharmaceutical industry